human parainfluenza vaccine
Showing 1 - 25 of >10,000
Human Metapneumovirus and Human Parainfluenza Infection Trial in United States (mRNA-1653, Placebo)
Completed
- Human Metapneumovirus and Human Parainfluenza Infection
- mRNA-1653
- Placebo
-
Birmingham, Alabama
- +18 more
Feb 2, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Ebola Virus Disease Trial in Baltimore (HPIV3/?HNF/EbovZ GP vaccine, Placebo)
Suspended
- Ebola Virus Disease
- HPIV3/ΔHNF/EbovZ GP vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Mar 2, 2022
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
Rabies Vaccine Adverse Reaction Trial in Changsha (Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose
Completed
- Rabies Vaccine Adverse Reaction
- Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program
- +3 more
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 9, 2023
Rabies Trial in Xiangyang (Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried)
Not yet recruiting
- Rabies
- Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried
-
Xiangyang, Hubei, ChinaGucheng Center for Disease Control and Prevention
Nov 19, 2023
Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)
Not yet recruiting
- Influenza, Human
- sa-mRNA vaccine Dose 1
- +4 more
- (no location specified)
Sep 7, 2023
Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula
Not yet recruiting
- Norovirus Infections
- Norwalk Gastroenteritis
- Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula polymorpha)
- placebo
- (no location specified)
Jun 14, 2023
Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant
Active, not recruiting
- Human Papillomavirus Infection
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +5 more
Jan 26, 2023
Human Metapneumovirus and Human Parainfluenza Infection Trial in Omaha, Austin, Fort Worth (mRNA-1653, Placebo)
Completed
- Human Metapneumovirus and Human Parainfluenza Infection
- mRNA-1653
- Placebo
-
Omaha, Nebraska
- +2 more
Feb 5, 2020
Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus Trial in Rolling Hills Estates, Miami,
Recruiting
- Respiratory Syncytial Virus Infection
- +2 more
- RSV/hMPV vaccine candidate Dose L
- +3 more
-
Rolling Hills Estates, California
- +2 more
Nov 14, 2023
Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)
Not yet recruiting
- Human Papillomavirus-Related Carcinoma
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +4 more
Aug 9, 2023
Yellow Fever Trial in Leiden (Yellow Fever Vaccine)
Recruiting
- Yellow Fever
- Yellow Fever Vaccine
-
Leiden, NetherlandsLeiden University Medical Center
Jun 12, 2023
Cytomegalovirus Infections Trial in Manchester (SPYVAC01)
Not yet recruiting
- Cytomegalovirus Infections
- SPYVAC01
-
Manchester, United KingdomMedicines Evaluation Unit
Nov 20, 2023
Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Completed
- Human Papilloma Virus Infection
- Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
- Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
-
Nanjing, Jiangsu, ChinaCDC, Jiangsu Province
Jan 12, 2023
Coronavirus Trial (OVX033, Saline solution)
Not yet recruiting
- Coronavirus
- OVX033
- Saline solution
- (no location specified)
Nov 14, 2023
Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)
Not yet recruiting
- Rabies
- 5-dose group of test vaccine
- +3 more
-
Chengdu, Sichuan, China
- +3 more
Jul 23, 2023
Rabies Vaccine Adverse Reaction, Safety and Efficacy Trial in Changsha (Freeze-dried human rabies vaccine (Vero cells)
Recruiting
- Rabies Vaccine Adverse Reaction
- Safety and Efficacy
- Freeze-dried human rabies vaccine (Vero cells) Zhifeilongkoma - 5-dose program
- +3 more
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Sep 21, 2022
Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)
Not yet recruiting
- Esophageal Cancer
- +3 more
- IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
-
Edegem, BelgiumAntwerp University Hospital
Jul 19, 2023
Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus
Completed
- Human Papillomavirus Infection
- Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
- Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
-
Nanjing, Jiangsu, ChinaCDC, Jiangsu Province
Jan 12, 2023
Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis
Enrolling by invitation
- Cervical Carcinoma
- Human Papillomavirus Infection
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
- +3 more
-
Liberia, Guanacaste, Costa RicaAgencia Costarricense de Investigaciones Biomédicas - Fundación
Aug 11, 2022
Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)
Not yet recruiting
- Human Papillomavirus Infection
- Human papillomavirus (HPV) Vaccine
- Placebo
-
Canberra, AustraliaParatus Clinical Research Canberra
Jan 4, 2023
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)
Recruiting
- Influenza A
- Pandemic Influenza
- H7HLAII
-
Oslo, NorwayOslo University Hospital
Sep 20, 2023
High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle
Terminated
- High Grade Anal Canal Intraepithelial Neoplasia
- High Grade Vulvar Squamous Intraepithelial Lesion
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +1 more
Jan 24, 2023